CellWise outsources the wet-lab sequencing and does the hard part in software: turning a high-dimensional single-cell dataset into a structured, clinician-ready read, with the quality control and population context that makes it defensible.
CellWise stays software-only. The wet lab happens at a CRO; everything that turns raw data into a clinical read happens here.
The sample is run through a single-cell licensed CRO. CellWise never touches a wet lab, so there's nothing new to build or staff.
Strict filtering removes apoptotic cells, and MAD statistics normalize the donor against a dynamic population baseline, eliminating batch effects while preserving rare signal.
Seven modules read the cleaned data: phenotyping, the peptide atlas, the aging profile, target mapping, and more, all anchored to the patient's Master Data Table.
A structured, clinician-ready report, plus assay-independent surveillance that keeps earning between screens without a repeat sequence.
The clinical home base. Use-case assessments, immuno-metabolic phenotyping, the therapeutic target map, stress profiling, and more, all in one report.
The quantitative, visual view of the patient's raw biomarker data, shown as a population-vs-patient overview.
A filterable, gene-level interface over the patient's complete dataset, exposing the top cell populations carrying each signal.
Test a clinical hypothesis against the patient's own molecular data and re-run it in seconds.
Assay-independent surveillance across dosing phases, peptide-specific labs, and wearable trends, with no repeat sequence required.
Immune age, senescence, and the 12 hallmarks from one PBMC sample, for cell-resolved biological aging.
Re-assay a patient and see the gene-expression deltas across key biomarkers, so you see what has shifted since the last screen.
What the platform reads, ranks, and connects to.